Types of Dermal Fillers Explained
"Types of dermal fillers" is not one classification but five, running in parallel. The same product can be described by its base material, its physical form, its rheology (how firm and how elastic it is), the tissue layer it is placed in, and how long it lasts. Clinical suppliers, procurement teams and regulators each use a different one of those five axes — which is why two people can both be talking about "filler types" and mean entirely different things.
Most guides to types of dermal fillers stop at the material list. This page sets out all five classification systems side by side, with the material properties that actually drive the differences, and maps them to the product formats a clinic or distributor orders. It is written for practitioners, clinic owners and buyers rather than patients. If you are new to the category, start with what dermal fillers are; if you are sourcing, the complete dermal filler guide covers the wider buying picture.
Types of Dermal Fillers: The Five Classification Systems
Almost every filler on the market can be positioned on five independent axes. Two products made from the same material can sit at opposite ends of the rheology axis and be used in completely different parts of the face.
| Axis | What distinguishes the types | Who uses this axis |
|---|---|---|
| Base material | Hyaluronic acid, calcium hydroxylapatite, poly-L-lactic acid, PMMA, polycaprolactone, autologous fat | Regulators, procurement, clinical selection |
| Physical form | Smooth gel, gel with suspended particles, lyophilised powder for reconstitution | Manufacturing, handling and reconstitution training |
| Rheology | Elastic modulus (G-prime), cohesivity, lift capacity — soft through to firm | Practitioners choosing depth and technique |
| Placement depth | Superficial/fine, dermal, deep dermal, subskin or supraperiosteal | Practitioners; the axis that maps most directly to SKUs |
| Duration | Temporary, collagen-biostimulatory, semi-permanent, permanent | Patients, clinics building a treatment plan, buyers |
A supplier's catalogue usually mixes all five. "1 ml cross-linked HA for mid-dermal placement" is one product described on four axes at once — material, form, rheology and depth.
Types by Material: The Six Families in Clinical Use
Material is the axis most people mean when they ask how many types of dermal fillers there are, and it is the axis regulators care about most, because it determines whether the product is absorbed, how it behaves if something goes wrong, and whether an antidote exists. The FDA groups filler materials into temporary formulations, one semi-permanent option, and describes them by origin rather than by brand. The American Society of Plastic Surgeons publishes a parallel taxonomy by material family, which is the classification used in the table below.
| Family | Composition | Primary mechanism | Reversible |
|---|---|---|---|
| Hyaluronic acid (HA) | A sugar naturally present in the body, cross-linked into a stable gel | Immediate volume; binds water | Yes — hyaluronidase |
| Calcium hydroxylapatite (CaHA) | A mineral and major component of bone, formed into microspheres suspended in a gel carrier | Immediate volume, then collagen response around the microspheres | No |
| Poly-L-lactic acid (PLLA) | A biodegradable synthetic polymer, supplied as a powder for reconstitution | Collagen biostimulation — no immediate volume | No |
| PMMA | Polymethylmethacrylate microspheres suspended in a collagen solution | Permanent volume with a collagen scaffold | No — the only non-absorbable FDA-approved option |
| Polycaprolactone (PCL) | A biodegradable polyester in a gel carrier | Volume plus gradual collagen response | No |
| Autologous fat | The patient's own harvested tissue | Volume with a graft take rate that varies | No — surgical, not injectable in the same sense |
Two practical points follow from this table. First, reversibility is unique to HA — it is the only family with an enzyme antidote, which is why clinics that are new to injectables are usually advised to build their first formulary around it. Second, PLLA and CaHA sit in a different category again: they are biostimulators, whose final result depends partly on how the patient's own tissue responds, not only on what was injected. The ASPS dermal filler overview describes the biostimulation mechanism on the same terms.

Hyaluronic Acid: The Largest Family, Split Four Ways
HA accounts for the overwhelming majority of filler procedures, and within HA the "types" question is really four separate questions.
Cross-linked versus non-cross-linked
Native HA is broken down by the body within days. Cross-linking — bonding the HA chains to one another with a linker such as BDDE — creates a stable three-dimensional network that resists degradation for months. Cross-linked HA is what fills folds; non-cross-linked HA is used for hydration and skin quality, where the goal is not volume but water retention in the superficial dermis. The two are not interchangeable, and a procurement specification that says only "hyaluronic acid" without stating the cross-linking status is incomplete.
Monophasic versus biphasic
Monophasic fillers are a single continuous gel phase. Biphasic fillers suspend gel particles in a fluid carrier, so the injected material contains both a solid and a liquid fraction. Monophasic products are generally described as smoother and more cohesive; biphasic products are often described as firmer at the point of injection. The distinction matters for handling and for how evenly the material distributes in the plane.
Depth grades — where the range becomes SKUs
The most commercially visible HA classification is by intended depth. Manufacturers formulate the same base material at different cross-linking densities and gel firmness so it can be matched to the layer it is placed in.

Calcium Hydroxylapatite: Microspheres in a Carrier
CaHA is a suspension rather than a gel: calcium hydroxylapatite microspheres are dispersed in a gel carrier. The carrier delivers immediate volume; the microspheres then act as a scaffold around which the body lays down new collagen. This dual behaviour is why CaHA is often positioned for deeper structural areas where a firmer product and a longer window are wanted, and why its effect builds over weeks rather than appearing all at once.
Manufacturing differences inside the CaHA family centre on two things: the size distribution of the microspheres, and what the carrier is made of. Older formulations used a carboxymethylcellulose carrier; newer ones pair the microspheres with a hyaluronic acid carrier, which combines the immediate volumising behaviour of HA with the longer-term response of the mineral. The CaHA range shows both formats, and the composition breakdown covers the carrier chemistry in more detail.

Poly-L-Lactic Acid: Biostimulation Rather Than Volume
PLLA is supplied as a lyophilised powder that is reconstituted with sterile water before injection. It is not a volumiser in the way HA is: it produces little immediate correction, and its result appears gradually as the polymer stimulates collagen deposition. Practitioners describe the onset in weeks rather than minutes, and the effect building over a course of sessions rather than a single appointment.
Because the material is a powder rather than a pre-filled gel, reconstitution technique is part of the product specification — the volume of diluent used changes the concentration and therefore the behaviour. A buyer comparing PLLA offers should treat hydration volume, vial fill weight and the instruction-for-use document as part of the product, not as an afterthought. The PLLA range lists the fill weight and reconstitution volume per line.

Types by Rheology: Why G-Prime Decides Where a Filler Goes
Rheology is the axis that separates two products made from identical material. The key measure is the elastic modulus, usually written G-prime — a number describing how firmly a gel resists deformation. A high G-prime filler holds its shape under the pressure of the tissue above it; a low G-prime filler flows and spreads.
| Rheology class | Behaviour | Typical placement | Typical format |
|---|---|---|---|
| Low G-prime, low viscosity | Spreads easily, minimal lift | Superficial dermis; skin hydration | Non-cross-linked or lightly cross-linked, 1 ml |
| Medium G-prime | Moderate lift, good conformity | Mid-dermal; folds and lines | Cross-linked, 1 ml |
| High G-prime | Holds projection under load | Deep dermal to subdermal; contouring | Densely cross-linked, 1–2 ml |
| Very high G-prime | Structural support, minimal migration | Subskin or supraperiosteal | Dense gel or particle suspension, larger fill |
A clinic that buys a single "generic filler" without checking this axis will find the product behaves acceptably in one area and poorly in another. The mechanism of how fillers work explains what G-prime is doing at the tissue level.
Types by Placement Depth: Fine, Derm, Deep and Subskin
Depth is the classification most visible on a product catalogue, because it is the one that maps directly to a purchase order. The four conventional grades run from the superficial dermis down to the deep plane.
| Depth grade | Layer | Intended correction | AuroThread line |
|---|---|---|---|
| Fine | Superficial dermis | Fine lines, skin quality, hydration | Fine non-cross-linked · Fine cross-linked |
| Derm | Mid dermis | Moderate folds and wrinkles | Derm HA |
| Deep | Deep dermis to subdermal | Volume restoration, fold support | Deep HA |
| Subskin | Subcutaneous / deep plane | Structural support and projection | Subskin HA |
The four grades are not simply "thin to thick". Each has a target plane, a needle or cannula length that suits it, and a rheology matched to the load that plane experiences. Supplying a clinic with a depth-graded range rather than a single line is what allows it to cover a full treatment menu from one documentation set.
Documented specification by depth grade
The table below sets out the published parameters for each grade in the AuroThread HA range, so the depth classification can be checked against numbers rather than descriptions. Where a parameter is not published for a grade, the cell is left as "not published" rather than estimated.
| Grade | Documented injection layer | Needle size | HA concentration | Gel particles / ml | Particle size (mm) |
|---|---|---|---|---|---|
| Fine | Upper part of the dermis | 27G | 20 mg/ml | 200,000 | 0.10~0.15 |
| Derm | Middle part of the dermis | 27G | 20 mg/ml | 100,000 | 0.15~0.28 |
| Deep | Deep layer of the dermis and/or surface layer of the subcutis | 26G | 20 mg/ml | 10,000 | Not published |
| Subskin | Deep dermis or subcutaneous tissue | Not published | Not published | 5,000 | 0.5~1.25 |
Two patterns in that table illustrate the depth axis better than any description. Particle size increases and particle count falls as the grade gets deeper — Fine carries 200,000 particles per millilitre at 0.10~0.15 mm, while Subskin carries 5,000 at 0.5~1.25 mm. And the needle gauge moves from 27G to 26G as the target layer deepens. Both are direct consequences of matching gel behaviour to the mechanical load of the plane.
At the range level, the same documentation records hyaluronic acid of non-animal origin, cross-linked with BDDE with residual content below the regulatory threshold, at a concentration of 20–24 mg/mL depending on viscosity grade. Sterilisation is by moist heat terminal sterilisation with each unit individually packaged; shelf life is two years from the date of manufacture; storage is 2–25°C. The range carries CE Mark, ISO 13485 QMS and GMP facility certification, and is documented as compatible with 27G–30G needles and 22G–30G blunt cannulas. Users match a grade to a plane, not a single product to every plane.
Types by Duration — and Why Published Numbers Conflict
Duration is the axis on which published sources disagree most, and the disagreement is not random — it reflects differences in measurement and in what is being measured. Set side by side, the major clinical sources give the following ranges.
| Source | Hyaluronic acid | Calcium hydroxylapatite | Poly-L-lactic acid |
|---|---|---|---|
| American Academy of Dermatology | 4–12 months | 6 months – 1 year | 1–3 years |
| Healthline clinical review | 6–12 months | 9–15 months | Collagen response; not expressed as a fixed term |
| Cleveland Clinic | 6 months – 1 year | Around 1 year | 2 years or more |
| Johns Hopkins Medicine | Not expressed as a fixed term | Up to 3 years for wrinkles; up to 1 year for contouring | Up to 2 years |
| AuroThread product specification (manufacturer-stated) | 6–18 months | Over 6 months | 2–3 years |
The final row is a manufacturer specification for the products in this range, not a clinical finding, and is labelled as such. It is given here so a buyer can see where our own documented figures sit relative to the clinical literature. Any product claim about duration should be read against the instructions for use of the specific line.
Read together, three conclusions hold across every source. HA is consistently the shortest-lived family. PLLA is consistently the longest-lived of the three absorbable materials. CaHA sits between them, but its reported range widens enormously depending on whether the source is measuring wrinkle correction or contouring — which is why a single number quoted without context is close to meaningless.
A second pattern is worth noting for anyone building patient-facing material: the sources that give precise numbers often disagree, while the sources that avoid numbers are the ones whose cells leave the field blank. Quoting a converged range with its source attached is more defensible than quoting a single figure, and it is also what clinical reviewers reward.
The AuroThread Range Mapped to Filler Types
AuroThread manufactures across the three absorbable material families, so a clinic or distributor can cover the classification axes above from one supplier rather than reconciling documentation from three. The mapping from types of dermal fillers to product line is as follows.
| Line | Material and type | Format | Where it fits |
|---|---|---|---|
| Auro Secret Plus | Cross-linked HA, depth-graded | 1mL, 2mL, 3mL and 10mL pre-filled syringe options, individually packaged | The working HA line across all four depth grades |
| UniCaHA | CaHA microspheres in an HA carrier | 1.1 ml syringe | Deeper structural areas wanting a firmer product and longer window |
| Angelfill | PLLA, lyophilised powder | 150 mg (PLLA) lyophilised vial | Collagen biostimulation; gradual onset, longest duration |
Browse the full dermal filler range for the complete SKU list including multi-specification packs, or see the definition of a dermal filler for how a single syringe is described and packaged.
How to Verify Which Type a Filler Actually Is
Marketing language blurs the classification axes, so the type a product claims to be and the type it is documented to be can diverge. Four documents settle the question.
| Document | What it establishes |
|---|---|
| Instructions for use (IFU) | The intended layer, needle specification, volume and stated duration for that product |
| Declaration of conformity / certificate | Which regulatory route the product was placed on the market under, and by whom |
| Technical data sheet | Concentration, cross-linking status, carrier composition, particle size where relevant |
| Batch release or certificate of analysis | That the specific batch supplied matches the specification on file |
If a supplier cannot produce the first two on request, the product's type is an assertion rather than a documented fact. For a wider checklist covering manufacturer verification, see the complete dermal filler guide.
Sources
The clinical figures and regulatory statements on this page are taken from the following published sources. Links open the original document.
- US Food and Drug Administration — Dermal Filler Do's and Don'ts — device classification, approved uses, material descriptions and the warning on unapproved fillers.
- American Academy of Dermatology — Fillers: FAQs — the filler duration and onset table by material.
- American Academy of Dermatology — Fillers: Overview — terminology, including the alternative names for soft-tissue fillers.
- Cleveland Clinic — Dermal Fillers — material-by-material duration figures and the annual treatment volume estimate.
- American Society of Plastic Surgeons — Types of Dermal Fillers — material taxonomy, CaHA production, and the history of polylactic acid as a suture material.
- Healthline — Considering Dermal Fillers — clinically reviewed duration ranges for HA and CaHA.
- Medical News Today — Botox and dermal fillers compared — mechanism contrast and the reversibility of hyaluronic acid.
- Johns Hopkins Medicine — Dermal Fillers — CaHA duration by indication and PLLA duration. Cited for the duration comparison; this source blocks automated verification and is not hyperlinked.
Frequently asked questions
Select a question to open the answer.
How many types of dermal fillers are there?
There is no single number, because there are five independent classification systems. Types of dermal fillers by material run to around six families in clinical use: hyaluronic acid, calcium hydroxylapatite, poly-L-lactic acid, PMMA, polycaprolactone and autologous fat. The same products are then re-divided by physical form, rheology, placement depth and duration. A supplier catalogue typically groups them by depth, because that is the axis that maps to a purchase order.
What is the most common type of dermal filler?
Hyaluronic acid. It is the most widely used filler material in cosmetic facial procedures, and it is the only family with an enzyme antidote: hyaluronidase can dissolve it if the result is unsatisfactory or a complication occurs. That combination of ubiquity and reversibility is why new injectors are usually advised to build their first formulary around HA.
What is the difference between collagen fillers and hyaluronic acid fillers?
Historically, collagen fillers were animal-derived products that required skin testing before use. Hyaluronic acid is a sugar found naturally in the human body and is produced by fermentation rather than harvested from animals, so no pre-treatment skin test is required. Hybrid products exist: PMMA fillers suspend synthetic microspheres in a collagen solution and remain the only non-absorbable FDA-approved option. Modern "collagen filler" marketing usually refers to biostimulators that prompt the body to produce its own collagen, not to injected collagen.
Which type of dermal filler lasts longest?
Among the absorbable materials, poly-L-lactic acid. Published sources give PLLA a range of roughly one to three years depending on the source and the indication, with several sources stating up to two years. CaHA is generally reported as lasting longer than HA but shorter than PLLA. PMMA is the exception to all of this: it is not absorbed, and is described as permanent.
Why do different websites give different durations for the same filler?
Because they are measuring different things. A source reporting how long a product corrects a wrinkle and a source reporting how long it maintains facial contouring are answering different questions with the same material, and the answers differ substantially. The CaHA range is the clearest example: one major clinical source reports up to three years when used for wrinkles and up to one year when used for contouring. Quoting a range with its source attached is more accurate than quoting a single figure.
What is the difference between monophasic and biphasic fillers?
A monophasic filler is a single continuous gel phase, which is generally described as smoother and more cohesive. A biphasic filler suspends gel particles in a fluid carrier, so the injected material has both a solid and a liquid fraction, and is often described as firmer at the point of injection. Both are hyaluronic acid products; the difference is in how the gel is processed, not in the base material.
What does G-prime mean in a filler specification?
G-prime is the elastic modulus — a measure of how firmly a gel resists deformation. A high G-prime filler holds its shape under the weight of the tissue above it and is used for structural support in deeper planes. A low G-prime filler spreads easily and is used superficially. Two products made from the same material can sit at opposite ends of this scale, which is why material alone does not determine where a filler can be used.
Are dermal fillers classified as drugs or medical devices?
As medical devices, not drugs, in both the United States and the European Union. The FDA states explicitly that it regulates dermal fillers as medical devices. That classification drives the documentation a supplier must hold — device registration, technical file, declaration of conformity — and it is the reason a buyer should expect an instructions-for-use document and a certificate rather than a drug leaflet.
Does a firm filler always last longer than a soft one?
No. Firmness and duration are different properties. G-prime describes how the gel resists deformation, while duration is governed by how resistant the material is to enzymatic and metabolic breakdown — for HA, that is largely a function of cross-linking density, and for biostimulators it depends on particle size and the tissue response. A product can be relatively soft and long-lasting, or firm and comparatively short-lived.
Which documents confirm the type of filler I am buying?
Four: the instructions for use, which state the intended layer and volume; the declaration of conformity or certificate, which establishes the regulatory route; the technical data sheet, which states concentration, cross-linking status and carrier composition; and a batch certificate of analysis confirming the supplied batch matches that specification. Without the first two, the product's type is a marketing claim rather than a documented property.
Can different filler types be combined in one treatment plan?
Yes, and combining materials from different families is common practice, because they occupy different depths and act by different mechanisms. A typical staged plan might use a firm product for structural support in a deep plane and a softer one for superficial lines in a later session. Because the planning and sequencing decisions belong to the treating practitioner and depend on the individual patient, this page covers the types and their properties rather than protocols.
Supplying a clinic or building your own filler brand? AuroThread manufactures across hyaluronic acid, calcium hydroxylapatite and poly-L-lactic acid with documentation and OEM capability. Request wholesale pricing and samples · Browse the dermal filler range
